Send us Feedback

Pharsight Corp (PHST)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

PHST » Topics » Reporting and Analysis Services (RAS)

This excerpt taken from the PHST 8-K filed May 8, 2008.

Reporting and Analysis Services (RAS)

 

  •  

Engaged six new customers.

 

  •  

Integrated PKS with WinNonlin and AutoPilot in a validated solution for regulatory studies.

 

  •  

Expanded the RAS team in response to global demand for the group’s services; team now totals 12 professionals.

 

  •  

Achieved continued strong revenue growth; RAS revenue up 86% quarter over quarter.

This excerpt taken from the PHST 8-K filed Jan 24, 2008.

Reporting and Analysis Services (RAS)

 

  •  

Engaged in a total of 20 different projects for the business unit, including projects with VIVUS, Inc., Hyperion, and Alexion Pharmaceuticals.

 

  •  

Achieved quality assurance milestone; audits of RAS unit conducted by three global biopharmaceutical companies.

 

  •  

Expanded the RAS team in response to global demand for the group’s services; team now totals 10 professionals.

 

  •  

Achieved continued strong revenue growth; RAS revenue grew 36% sequentially compared with the prior quarter.

This excerpt taken from the PHST 8-K filed Oct 25, 2007.

Reporting and Analysis Services (RAS)

 

  •  

Engaged in 13 different projects for the business unit, including projects with 3 customers new to Pharsight: Lupin Pharmaceuticals, Seattle Genetics and NeurogesX

 

  •  

Expanded the RAS team with the addition of four scientific specialists.

 

  •  

Continued to expand the internship program with the first intern hire within RAS.

 

  •  

Signed a $265,000 agreement with a global biotechnology company for regulatory population pharmacokinetics and pharmacodynamic analysis and reporting.

 

  •  

Achieved positive margin and strong revenue growth; RAS revenue grew 30% sequentially compared with the fiscal first quarter of 2008.

This excerpt taken from the PHST 8-K filed Jul 26, 2007.

Reporting and Analysis Services (RAS)

 

  •  

Signed six new consulting agreements during fiscal first quarter, including four with customers new to Pharsight: Novartis Consumer Health, ZARS, NPS Pharmaceuticals and Corcept.

 

  •  

Increased capacity of business unit with hiring of additional scientists.

“We were very pleased to enter into our first six consulting agreements with our newly formed Reporting and Analysis Services unit,” continued Mr. O’Connor. “We believe that this unit, which

leverages and expands our existing software and consulting strengths, can grow to become a meaningful contributor to revenue in the future. In addition, through our new service offering we were able to garner four customers that are new to Pharsight. We believe that the complementary nature of our software, SCS and RAS business units bodes well for cross-selling opportunities in the future.”

EXCERPTS ON THIS PAGE:

8-K
May 8, 2008
8-K
Jan 24, 2008
8-K
Oct 25, 2007
8-K
Jul 26, 2007

RELATED TOPICS for PHST:

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki